Status:
UNKNOWN
Most Preventable Surgical Option to Reduce Primary Spontaneous Pneumothorax Patients' Postoperative Recurrence: A Prospective Cohort Study
Lead Sponsor:
Yuka Kadomatsu
Conditions:
Spontaneous Pneumothorax
Recurrence
Eligibility:
All Genders
16-40 years
Brief Summary
To investigate the most preventable option to reduce primary spontaneous postoperative recurrence.
Detailed Description
Pneumothorax is a disease in which air in the lungs leaks into the pleural cavity. It is a disease that occurs most often in young people with active social activities, and it occurs in about 100,000 ...
Eligibility Criteria
Inclusion
- Patients who have spontaneous pneumothorax diagnosed by radiography and plan to underwent initial VATS bullectomy.
- Patients who receive informed consent to attend this study, and the agreements are provided in a document.
- The consent of parents is also required, in case patients are under 20-years old.
Exclusion
- History of ipsilateral chest surgery.
- Patients who only underwent exploratory surgery.
- Patients who are judged ineligible by the investigator and the attending surgeon.
Key Trial Info
Start Date :
August 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04758143
Start Date
August 11 2020
End Date
March 31 2025
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Surgery, Nagoya University Graduate School of Medicine
Nagoya, Japan, 466-8550